| Clinical data | |
|---|---|
| Other names | MRZ-8456 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H15BrN4O |
| Molar mass | 371.238 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Remeglurant (INNTooltip International Nonproprietary Name; developmental code nameMRZ-8456) is adrug which acts as aselectiveantagonist of themGlu5 receptor.[1][2][3] It is under development by Merz Pharmaceuticals for the treatment ofdrug-induced dyskinesia but no development has been reported since at least 2016.[3]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |